Pacific Therapeutics Announces Addition To Management Team
Pacific Therapeutics Ltd. (the "Company") is a clinical stage specialty pharmaceutical company focused on the repurposing and reformulation of existing FDA approved drugs for large markets. Mr. Doug Unwin, President and CEO of Pacific Therapeutics Ltd. (the "Issuer") is pleased to announce that the Issuer has engaged Ms. Wendy Chan (MBA'92) to fill the role as VP Strategy and Marketing on a part-time basis. The contract with Ms. Chan is for one year. Wendy Chan is a business strategist with over 17 years of business management experience, specializing in strategy, planning and negotiating strategic alliances and partnerships. She holds a BSc. from UBC and an MBA in Marketing and Finance from Ï㽶ÊÓƵ.
Read full article: , September 27, 2013
Feedback
For more information or if you would like to report an error, please web.desautels [at] mcgill.ca (subject: Website%20News%20Comments) (contact us).
